Your Prostrate.com logo
Google
Web yourprostate.com.au

Prostate News Archive

01-Jul-2011

  • Medicare Will Pay for Pricey Prostate Cancer Drug

    THURSDAY, June 30 (HealthDay News) -- The cost of Provenge, an expensive and newly approved therapeutic prostate cancer vaccine, will be covered by Medicare for men with metastatic prostate cancer, the agency announced late Thursday.


  • Medicare confirms payment for prostate cancer drug

    Medicare officials confirmed Thursday that the program will cover the $93,000 price tag for prostate cancer drug Provenge, an innovative therapy that typically gives men suffering from an incurable stage of the disease an extra four months to live.


  • Life after prostate surgery worse than men expect

    NEW YORK (Reuters Health) - Nearly half of men who undergo surgery to treat prostate cancer find themselves with greater incontinence problems and less sexual function than they had anticipated, according to a new poll.


  • Back to Prostate News Archive